FDA Approved: PROGRAF — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approves PROGRAF (tacrolimus) under the original application for prevention of organ transplant rejection in kidney, liver, and heart transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

ORIG AP for PROGRAF (TACROLIMUS)